A
Alydia Health
Fast Control of Abnormal Postpartum Uterine Bleeding
About Alydia Health
Alydia Health operates in the medical device industry, focusing on innovative solutions for postpartum hemorrhage (PPH) management. The company's flagship product, the Jada System, uses gentle suction to help the uterus contract naturally, aiming to reduce the need for surgical intervention and allow mothers to bond with their newborns peacefully. Alydia Health primarily serves healthcare providers, including hospitals and maternity clinics, who are looking for effective and minimally invasive solutions to manage PPH. The company generates revenue through the sale of its medical devices and related services. Currently, the Jada System is investigational and undergoing clinical trials, with promising initial results showing rapid hemorrhage control and minimal blood loss. Alydia Health operates in a niche market with significant growth potential, driven by the increasing focus on maternal health and safety.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 2011
- Headquarters
- Menlo Park, United States
- Employees
- 4
- Open positions
- None listed
- Dealroom signal
- 58.5/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Pregnancy, Surgery, Nursing, Women's Health, Femtech, Sustainable Development Goals, Child Birth, Hard Tech, DT and LS, science-based
- Technology
- Deep Tech
- Client focus
- b2b
Latest news
Press, funding announcements and product moves mentioning Alydia Health.
Funding history
Company financing events and reported valuations.
Growth signals
Latest recorded traffic for Alydia Health is 390 monthly website visits, down 92.8% over the last three months. Alydia Health's team declined 91.3% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
 VivoSensMedical GmbHCombines medical-scientific experience |
Leipzig, Germany | Operational | 10 | — | — |
 CorofloThe only accurate breastfeeding monitor |
Dublin, Ireland | Operational | |||
 LiluReinventing the already familiar pumping bra by embedding automated compression, |
New York City, United States | Operational | |||
 Cirqle BiomedicalDevelops a next generation contraceptive product |
Copenhagen, Denmark | Operational | |||
 NuvoNuvo is an emerging leader in maternal-fetal connected health |
Tel Aviv-Yafo, Israel | Operational | |||
 NUA SurgicalAward-Winning Irish Women's Health Company with a patented solution to improve maternal health outcomes. |
Galway, Ireland | Operational | |||
 InnitiusCervical Consistency + AI for improved accuracy in Birth Timing |
Derio, Spain | Operational | |||
 PregnoliaEnables to assess accurately the stiffness of the cervical tissue of pregnant and non-pregnant women |
Schlieren, Switzerland | Operational |
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Global Health Investment Corporation
Series B and later2 investors entered at this stage
AXA Investment Managers
Avestria Ventures
Other known investors1 additional known investor
Merck & Co.
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Alydia Health on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Alydia Health’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.